The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030

Results from a microsimulation model

Deborah Schofield, Michelle Cunich, Rupendra Shrestha, Megan Passey, Lennert Veerman, Robert Tanton, Simon Kelly

Research output: Contribution to journalArticle

1 Downloads (Pure)

Abstract

Background: Most studies measure the impact of ischemic heart disease (IHD) on individuals using quality of life metrics such as disability-adjusted life-years (DALYs); however, IHD also has an enormous impact on productive life years (PLYs). The objective of this study was to project the indirect costs of IHD resulting from lost PLYs to older Australian workers (45-64 years), government, and society 2015-2030. Methods: Nationally representative data from the Surveys of Disability, Ageing and Carers (2003, 2009) were used to develop the base population in the microsimulation model (Health&WealthMOD2030), which integrated data from established microsimulation models (STINMOD, APPSIM), Treasury's population and workforce projections, and chronic conditions trends. Results: We projected that 6700 people aged 45-64 were out of the labour force due to IHD in 2015, increasing to 8100 in 2030 (21 increase). National costs consisted of a loss of AU$273 (US$263) million in income for people with IHD in 2015, increasing to AU$443 ($US426) million (62% increase). For the government, extra welfare payments increased from AU$106 (US$102) million in 2015 to AU$143 (US$138) million in 2030 (35% increase); and lost income tax revenue increased from AU$74 (US$71) million in 2015 to AU$117 (US$113) million in 2030 (58% increase). A loss of AU$785 (US$755) million in GDP was projected for 2015, increasing to AU$1125 (US$1082) million in 2030. Conclusions: Significant costs of IHD through lost productivity are incurred by individuals, the government, and society. The benefits of IHD interventions include not only improved health but also potentially economic benefits as workforce capacity.

Original languageEnglish
Article number802
Pages (from-to)1-13
Number of pages13
JournalBMC Public Health
Volume19
DOIs
Publication statusPublished - 21 Jun 2019

Fingerprint

Myocardial Ischemia
Costs and Cost Analysis
Income Tax
Quality-Adjusted Life Years
Health
Caregivers
Economics
Quality of Life
Population

Cite this

Schofield, Deborah ; Cunich, Michelle ; Shrestha, Rupendra ; Passey, Megan ; Veerman, Lennert ; Tanton, Robert ; Kelly, Simon. / The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030 : Results from a microsimulation model. In: BMC Public Health. 2019 ; Vol. 19. pp. 1-13.
@article{38018083037948e98805306018284ed8,
title = "The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030: Results from a microsimulation model",
abstract = "Background: Most studies measure the impact of ischemic heart disease (IHD) on individuals using quality of life metrics such as disability-adjusted life-years (DALYs); however, IHD also has an enormous impact on productive life years (PLYs). The objective of this study was to project the indirect costs of IHD resulting from lost PLYs to older Australian workers (45-64 years), government, and society 2015-2030. Methods: Nationally representative data from the Surveys of Disability, Ageing and Carers (2003, 2009) were used to develop the base population in the microsimulation model (Health&WealthMOD2030), which integrated data from established microsimulation models (STINMOD, APPSIM), Treasury's population and workforce projections, and chronic conditions trends. Results: We projected that 6700 people aged 45-64 were out of the labour force due to IHD in 2015, increasing to 8100 in 2030 (21 increase). National costs consisted of a loss of AU$273 (US$263) million in income for people with IHD in 2015, increasing to AU$443 ($US426) million (62{\%} increase). For the government, extra welfare payments increased from AU$106 (US$102) million in 2015 to AU$143 (US$138) million in 2030 (35{\%} increase); and lost income tax revenue increased from AU$74 (US$71) million in 2015 to AU$117 (US$113) million in 2030 (58{\%} increase). A loss of AU$785 (US$755) million in GDP was projected for 2015, increasing to AU$1125 (US$1082) million in 2030. Conclusions: Significant costs of IHD through lost productivity are incurred by individuals, the government, and society. The benefits of IHD interventions include not only improved health but also potentially economic benefits as workforce capacity.",
keywords = "Cardiovascular disease, Income, Indirect costs, Ischemic heart disease, Microsimulation, Productivity",
author = "Deborah Schofield and Michelle Cunich and Rupendra Shrestha and Megan Passey and Lennert Veerman and Robert Tanton and Simon Kelly",
year = "2019",
month = "6",
day = "21",
doi = "10.1186/s12889-019-7086-5",
language = "English",
volume = "19",
pages = "1--13",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",

}

The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030 : Results from a microsimulation model. / Schofield, Deborah; Cunich, Michelle; Shrestha, Rupendra; Passey, Megan; Veerman, Lennert; Tanton, Robert; Kelly, Simon.

In: BMC Public Health, Vol. 19, 802, 21.06.2019, p. 1-13.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030

T2 - Results from a microsimulation model

AU - Schofield, Deborah

AU - Cunich, Michelle

AU - Shrestha, Rupendra

AU - Passey, Megan

AU - Veerman, Lennert

AU - Tanton, Robert

AU - Kelly, Simon

PY - 2019/6/21

Y1 - 2019/6/21

N2 - Background: Most studies measure the impact of ischemic heart disease (IHD) on individuals using quality of life metrics such as disability-adjusted life-years (DALYs); however, IHD also has an enormous impact on productive life years (PLYs). The objective of this study was to project the indirect costs of IHD resulting from lost PLYs to older Australian workers (45-64 years), government, and society 2015-2030. Methods: Nationally representative data from the Surveys of Disability, Ageing and Carers (2003, 2009) were used to develop the base population in the microsimulation model (Health&WealthMOD2030), which integrated data from established microsimulation models (STINMOD, APPSIM), Treasury's population and workforce projections, and chronic conditions trends. Results: We projected that 6700 people aged 45-64 were out of the labour force due to IHD in 2015, increasing to 8100 in 2030 (21 increase). National costs consisted of a loss of AU$273 (US$263) million in income for people with IHD in 2015, increasing to AU$443 ($US426) million (62% increase). For the government, extra welfare payments increased from AU$106 (US$102) million in 2015 to AU$143 (US$138) million in 2030 (35% increase); and lost income tax revenue increased from AU$74 (US$71) million in 2015 to AU$117 (US$113) million in 2030 (58% increase). A loss of AU$785 (US$755) million in GDP was projected for 2015, increasing to AU$1125 (US$1082) million in 2030. Conclusions: Significant costs of IHD through lost productivity are incurred by individuals, the government, and society. The benefits of IHD interventions include not only improved health but also potentially economic benefits as workforce capacity.

AB - Background: Most studies measure the impact of ischemic heart disease (IHD) on individuals using quality of life metrics such as disability-adjusted life-years (DALYs); however, IHD also has an enormous impact on productive life years (PLYs). The objective of this study was to project the indirect costs of IHD resulting from lost PLYs to older Australian workers (45-64 years), government, and society 2015-2030. Methods: Nationally representative data from the Surveys of Disability, Ageing and Carers (2003, 2009) were used to develop the base population in the microsimulation model (Health&WealthMOD2030), which integrated data from established microsimulation models (STINMOD, APPSIM), Treasury's population and workforce projections, and chronic conditions trends. Results: We projected that 6700 people aged 45-64 were out of the labour force due to IHD in 2015, increasing to 8100 in 2030 (21 increase). National costs consisted of a loss of AU$273 (US$263) million in income for people with IHD in 2015, increasing to AU$443 ($US426) million (62% increase). For the government, extra welfare payments increased from AU$106 (US$102) million in 2015 to AU$143 (US$138) million in 2030 (35% increase); and lost income tax revenue increased from AU$74 (US$71) million in 2015 to AU$117 (US$113) million in 2030 (58% increase). A loss of AU$785 (US$755) million in GDP was projected for 2015, increasing to AU$1125 (US$1082) million in 2030. Conclusions: Significant costs of IHD through lost productivity are incurred by individuals, the government, and society. The benefits of IHD interventions include not only improved health but also potentially economic benefits as workforce capacity.

KW - Cardiovascular disease

KW - Income

KW - Indirect costs

KW - Ischemic heart disease

KW - Microsimulation

KW - Productivity

UR - http://www.scopus.com/inward/record.url?scp=85068510210&partnerID=8YFLogxK

U2 - 10.1186/s12889-019-7086-5

DO - 10.1186/s12889-019-7086-5

M3 - Article

VL - 19

SP - 1

EP - 13

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

M1 - 802

ER -